Nutcracker Therapeutics

View the org chart displaying its 14 main executives

Most searched biographies at Nutcracker Therapeutics

• Igor Khandros, Chief Executive Officer and Chairman of the Board
• Michael Bigham, Director
• Cynthia Collins, Director

Popular executive movements at Nutcracker Therapeutics

• Samuel Deutsch, who was Executive Vice President, Research and Early Development, is promoted to Chief Scientific Officer  (posted on January 9 2024).

Create your alert
to follow the executive moves at Nutcracker Therapeutics.

Nutcracker Therapeutics has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).
• Enlaza Therapeutics has just announced a $100 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Nutcracker Therapeutics

• News – Nutcracker Therapeutics, Inc.
• News – Nutcracker Therapeutics, Inc.

Social media about Nutcracker Therapeutics

• Nutcracker Therapeutics on Wikipedia, Google News & Yahoo Finance
• Nutcracker Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Igor Khandros

Call Nutcracker Therapeutics at +1 510...

View the org chart

Register to receive your alert

Report an error